Transactions
1
Insider / GE HealthCare Technologies Inc.
Estrampes Catherine
Chief Commer. & Growth Officer at GE HealthCare Technologies Inc.
- Ticker
- GEHC
- First filing on record
- September 4, 2026
- Latest trade on record
- September 3, 2026
- SEC filings
- EDGAR ↗
Estrampes Catherine, Chief Commer. & Growth Officer at GE HealthCare Technologies Inc., has disclosed 1 transaction in GEHC since September 4, 2026: 0 purchases (0 open-market buys) and 1 sale, worth about $36K at the reported prices. The latest was filed September 4, 2026, 1 day after the trade.
Open-market buys
0
Sales
1
Avg. disclosure lag
1.0d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)
In the last 12 months Estrampes Catherine made no purchases and 1 sale worth $36K. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Estrampes Catherine has traded 1 stock on record; the largest by dollars is GEHC.
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| F | Shares withheld for tax | 1 | 508 | $36K |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 1 | 0 | 1 · $36K |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| GEHC | Sell F | September 3, 2026 | September 4, 2026 | 1d | 508 | $71 | $36K | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| September 4, 2026 | Form 4 | 0002131383-26-000006 | 1 | published | EDGAR ↗ |
Other insiders at GE HealthCare Technologies Inc.
- Jimenez Frank R Director 18 rows
- Arduini Peter J Director 15 rows
- Lobo Kevin Director 13 rows
- CULP H LAWRENCE JR Chairman and CEO 10 rows
- Rackliffe Philip CEO, AVS 10 rows
- Kass-Hout Taha Chief Technology Officer 8 rows
- SACCARO JAMES EVP, CFO & COO 7 rows
- Newcomb George A. Chief Accounting Officer 6 rows
- O'Neill Kevin Michael CEO, PDx 6 rows
- Grogan William K Director 5 rows
Everyone on file, with contracts and lobbying under the company's name: GE HealthCare Technologies Inc..
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 1 | 1 | September 4, 2026 | September 4, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.